Advertisement
New grant will fund work to map human bladder and ureter at a cellular and molecular level
A multidisciplinary team of researchers from Lerner Research Institute has been awarded a five-year, $2.4 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (part of the National Institutes of Health) to conduct the first-ever comprehensive analysis of the human bladder and ureter throughout the lifespan.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Non-cancerous urologic diseases (e.g., urinary tract infections, urinary incontinence and painful bladder syndrome) affect individuals of all ages, can lead to significant disability and decreased quality of life and cost more than $5 billion in healthcare expenditures each year in the United States.
“Development of effective novel therapies for these conditions has been hindered by our incomplete understanding of the lower urinary tract tissues at a cellular and molecular level,” says lead principal investigator Byron Lee, MD, PhD, joint staff in the Department of Cardiovascular & Metabolic Sciences and Glickman Urological and Kidney Institute.
“With this grant, we aim to generate a high-resolution transcriptome and gene regulatory dataset for healthy human ureter and bladder tissues in males and females at various ages. This will help us to construct an anatomical map of the organs that allows comprehensive understanding of their cellular and molecular characteristics during various life stages and points us closer to novel therapeutic targets.”
Using tissue samples from donors in three age groups that reflect distinct physiological states of lower urinary tract function, the researchers will collect data from five anatomic locations with unique tissue structures and functions. They then will use these data to analyze the lineage relationships between the different cell types, validate novel markers for each cell type and study underlying gene regulatory networks.
“These molecular data will become a valuable resource to the research community and, ultimately, will support efforts in organ repair and regeneration,” said Dr. Lee.
Advertisement
Angela Ting, PhD, associate staff in the Genomic Medicine Institute, and Oliver Wessely, PhD, associate staff in the Department of Cardiovascular & Metabolic Sciences, are also principal investigators on the grant.
Advertisement
Advertisement
Findings expand upon earlier data, providing new noninvasive options
Cleveland Clinic is the first to investigate photonic nanoparticles as a potential kidney stone treatment
Management of high-risk RMSK in the pre-and current eras of neoadjuvant therapy
The multidisciplinary research team reported their findings in JAMA
Physicians explain findings from a recent study
Study reviews institutional experience
Information on the microbiome and urologic pathologies remain relatively limited
First in-human-trial for diagnostic bladder disorder device